Health & Biotech
MGC Pharmaceuticals (ASX: MXC) has changed its name to Argent Biopharma - RGT (ASX: RGT).
Below are the previous articles from MGC Pharmaceuticals (ASX: MXC):
RELATED STOCKHEAD STORIES
Health & Biotech
Epilepsy sufferers rejoice as MGC Pharma’s CannEpil arrives in Australia
Health & Biotech
MGC Pharmaceuticals to accelerate growth listing on the U.S. OTC ventures market
Health & Biotech
Medical cannabis research is about to get a big boost
Health & Biotech
MGC undervalued as pharma and cannabis ingredients business expands: analyst
Health & Biotech
MGC Pharma’s cannabis-based epilepsy treatment approved for Australian patient sales
Health & Biotech
MGC Pharma teams up with Canadian cannabis industry pioneer Lorne Gertner
Health & Biotech
MGC Pharma to sell MGC Derma business to strategic partner
Health & Biotech
Distribution deal opens new international opportunities for MGC Pharma
Health & Biotech
MGC Pharma approved to trial the use of medical cannabis to treat dementia
Health & Biotech
MGC Pharma just extended a deal to stock its cannabis skincare range in Harvey Nichs
Health & Biotech
MGC Pharma brings in leading neurologist to drive product development and commercialisation in Australia
Health & Biotech
MGC Pharma now owns one of the most advanced cannabis production facilities in Europe
Health & Biotech
Great timing for MGC Pharma as Malta passes medicinal cannabis legislation
Health & Biotech
MGC Pharma to grow CBD and THC strains under new Maltese licence
Health & Biotech
MGC’s cannabis-based cosmetics join renowned brands at Cult Beauty
Health & Biotech
MGC Pharma to deliver cannabis epilepsy treatment to Aussies in early 2018
Health & Biotech